THE TAKETrailAI · auto-generated
Carter's contribution profile is balanced between PAC and committee funding (49%) and individual donors (51%), with $255K in separate party and leadership money. His industry-tied contributions concentrate in health services, pharmaceuticals and biotech, and legal/lobbying sectors, a pattern reflected among his individual donor base where health professionals, lawyers, and pharmaceutical industry workers predominate. With 334 recorded votes and one stock trade disclosure on file, his legislative activity and financial disclosures present a standard profile for a House member from his tenure period.
Raised · all cycles$7.4M▲ 13% in ’24 vs ’22#51 in party · by cycle ↴
Top sector share22%Health Services
Donor-sector votes16on bills touching top donor sectors
FOLLOW THE MONEY
Left: who funds Carter (ribbon width = dollars) · right: their votes on bills classified as favoring vs limiting those sectors
“Favors / limits” is an AI classification of each bill's likely effect on the sector — a factual reading of the bill, not a claim about motive. Correlation, not causation. The named bills are in DOES THE MONEY MATCH THE VOTES? below.
DOES THE MONEY MATCH THE VOTES?
How Carter voted on bills touching their biggest donor sectors · 6 of 16 shown, ranked by sector money
Each dollar figure is Carter's total from that donor sector — shown on each related vote, not a per-vote amount. Correlation between funding and votes, not causation; many factors shape any single vote.
TOP SOURCES
1$915K
TEAM BUDDY
PAC
2$118K
AMERIS BANK
corporation
3$64K
STIFEL
corporation
4$46K
AMERICAN ISRAEL PUBLIC AFFAIRS COMMITTEE PAC
PAC
5$45K
AMERICAN OPTOMETRIC ASSOCIATION POLITICAL ACTION COMMITTEE
PAC
ALIGNMENT SIGNALS
Sector-Aligned Voting90%
Earl L. "Buddy" Carter (R) voted YEA on 8 of 8 bills classified as favoring their donor sectors — #17 rate in the House
Rep. Earl L. "Buddy" Carter voted YEA on 100% of eight tracked bills classified as favoring his top donor sectors including Pharmaceuticals & Biotech and Retail & Consumer, ranking #17 among House members on this measure. He voted YEA on HR3537-117, the Accelerating Access to Critical Therapies for ALS Act, classified as favoring Pharmaceuticals & Biotech, and supported 3 of 4 bills classified as limiting those same sectors.
Committee–Donor Overlap73%
Earl L. "Buddy" Carter (R) sits on the Energy and Commerce committee overseeing Health Services — their largest tracked donor sector (21%)
Rep. Earl L. "Buddy" Carter (R-GA) serves on the House Committee on Energy and Commerce, which has jurisdiction over the Health Services sector. Health Services comprises 21.2% of his identifiable donor base ($1.57M), ranking 10th among Republican members in donor concentration from this sector.
LEGISLATION
2 sponsored
COMMITTEES
Energy and Commerce
Budget
SIMILAR DONOR NETWORKS
Members funded by the same industries — overlapping donor networks may reflect shared policy interests.
Roger Marshall
R-KS · Senate
Health ServicesPharmaceuticals & BiotechLawyers & Lobbyists
Diana Harshbarger
R-TN · House
Health ServicesPharmaceuticals & BiotechLawyers & Lobbyists
Gus M. Bilirakis
R-FL · House
Health ServicesPharmaceuticals & BiotechLawyers & Lobbyists
Gregory F. Murphy
R-NC · House
Health ServicesPharmaceuticals & BiotechLawyers & Lobbyists
James Comer
R-KY · House
Health ServicesPharmaceuticals & BiotechLawyers & Lobbyists
H. Morgan Griffith
R-VA · House
Health ServicesPharmaceuticals & BiotechLawyers & Lobbyists